Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy.
Westhoff
Timm H
TH
Jochimsen
Friederike
F
Schmittel
Alexander
A
Stoffler-Meilicke
Marina
M
Schafer
Jurgen H
JH
Zidek
Walter
W
Gerlich
Wolfram H
WH
Thiel
Eckhard
E
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D006509:Hepatitis B / Q000209:etiology*; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D009154:Mutation; D012008:Recurrence; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab